Top Wall Street analysts changed their outlook on these top names.

For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Baird analyst David Rescott initiated coverage on Abbott Laboratories (NYSE:ABT) with an Outperform rating and announced a price target of $121.

Abbott shares closed at $90.74 on Tuesday.

See how other analysts view this stock.